The owner of an Istanbul, Turkey-based pharmaceutical company has pleaded guilty in a Missouri federal court to charges that he shipped illegal cancer-treatment drugs into the United States. Sabahaddin Akman reportedly faces up to 20 years in prison; he has agreed to pay a $150,000 fine, if imposed by the court, and a $150,000 forfeiture payment to the United States. Akman allegedly used shipping labels to conceal the nature of the shipments, including false customs declarations describing the contents as gifts, and divided large drug shipments into smaller packages to reduce the likelihood of seizures by customs authorities. Some of the drugs Akman shipped to the United States needed constant cold temperatures to maintain stability and effectiveness, but he failed to provide any temperature protection. The drugs allegedly did not meet U.S. Food and Drug Administration (FDA) standards and had not been approved for use in the United States. See Department of Justice Press Release, August 12, 2014; FDA News Release, August 15, 2014.